SSRIs

The association between maternal use of antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) during pregnancy, and birth defects in newborns and infants, has been the topic of much discussion in recent years. A new study, published in the BMJ, finds a small increased risk of two SSRIs (Paxil/paroxetine and Prozac/fluoxetine) with some birth defects, but not others (including the most commonly used SSRI,
Previous studies have suggested that pregnant women taking a commonly-prescribed class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) late in pregnancy may be associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN). PPHN (also known as persistent fetal circulation) is a